UBS’s Labcorp LH Stock Holding History

UBS’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-8,497	Closed	-$717K	–	10637
2014 Q1	$717K	Buy	8,497 +465	+6%	+$37.1K	﹤0.01%	3851
2013 Q4	$630K	Buy	+8,032	New	+$685K	﹤0.01%	4069
2013 Q3	–	Sell	-10,592	Closed	-$911K	–	10554
2013 Q2	$911K	Buy	+10,592	New	+$879K	﹤0.01%	3447

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

UBS's LH Position: Q3 2014 in Review

UBS reduced its Labcorp (LH) stake by 3.8% in Q3 2014, selling an estimated $218K and leaving 61,087 shares worth $5.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1961.

UBS first reported a position in LH in Q2 2013 and has held it in 6 quarters since. The position peaked at $6.2M in Q1 2014. 525 funds tracked by Wall St. Rank hold LH as of Q3 2014.

UBS held 61,087 shares of Labcorp worth $5.34M as of Q3 2014.
UBS sold 2,412 Labcorp shares in Q3 2014, an estimated $218K.
Labcorp made up ﹤0.01% of UBS's portfolio in Q3 2014, its #1961 holding.
UBS first reported a position in Labcorp in Q2 2013 and has held it in 6 quarters since.
UBS's Labcorp position peaked at $6.2M in Q1 2014.
525 funds tracked by Wall St. Rank held Labcorp as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.